Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beam Therapeutics (BEAM) Return on Sales: 2021-2025

Historic Return on Sales for Beam Therapeutics (BEAM) over the last 4 years, with Sep 2025 value amounting to -7.57%.

  • Beam Therapeutics' Return on Sales fell 716.00% to -7.57% in Q3 2025 from the same period last year, while for Sep 2025 it was -7.57%, marking a year-over-year decrease of 716.00%. This contributed to the annual value of -5.93% for FY2024, which is 558.00% down from last year.
  • Beam Therapeutics' Return on Sales amounted to -7.57% in Q3 2025, which was down 12.49% from -6.73% recorded in Q2 2025.
  • Beam Therapeutics' 5-year Return on Sales high stood at -0.37% for Q4 2023, and its period low was -420.36% during Q3 2021.
  • Its 3-year average for Return on Sales is -3.60%, with a median of -3.84% in 2023.
  • As far as peak fluctuations go, Beam Therapeutics' Return on Sales spiked by 41,705bps in 2022, and later slumped by 716bps in 2025.
  • Beam Therapeutics' Return on Sales (Quarterly) stood at -6.79% in 2021, then soared by 223bps to -4.56% in 2022, then soared by 419bps to -0.37% in 2023, then crashed by 558bps to -5.95% in 2024, then slumped by 716bps to -7.57% in 2025.
  • Its Return on Sales stands at -7.57% for Q3 2025, versus -6.73% for Q2 2025 and -6.22% for Q1 2025.